Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Data-Based Analysis, Modelling and Forecasting of the novel Coronavirus (2019-nCoV) outbreak

Cleo Anastassopoulou, Lucia Russo, Athanasios Tsakris, Constantinos Siettos
doi: https://doi.org/10.1101/2020.02.11.20022186
Cleo Anastassopoulou
1Department of Microbiology, Medical School, University of Athens, Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: cleoa{at}med.uoa.gr
Lucia Russo
2Consiglio Nazionale delle Ricerche, Science and Technology for Energy and Sustainable Mobility, Naples, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Athanasios Tsakris
1Department of Microbiology, Medical School, University of Athens, Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Constantinos Siettos
3Dipartimento di Matematica e Applizazioni, Università degli Studi di Napoli Federico II, Napoli, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: csiettos{at}gmail.com
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Since the first suspected case of coronavirus diesease-2019 (COVID-19) on December 1st, 2019, in Wuhan, Hubei Province, China, a total of 40,235 confirmed cases and 909 deaths have been reported in China up to February 10, 2020, evoking fear locally and internationally. Here, based on the publicly available epidemiological data (WHO, CDC, ECDC, NHC and DXY) for Hubei from January 11 to February 10, 2020, we provide estimates of the main epidemiological parameters, i.e. the basic reproduction number (R0) and the infection, recovery and mortality rates, along with their 90% confidence intervals. As the number of infected individuals, especially of those with asymptomatic or mild courses, is suspected to be much higher than the official numbers, which can be considered only as a sample of the actual numbers of infected and recovered cases in the population, we have repeated the calculations under a second scenario that considers twenty times the number of confirmed infected cases and forty times the number of recovered, leaving the number of deaths unchanged. Our computations and analysis were based on a mean field Susceptible-Infected-Recovered-Dead (SIRD) model. Thus, based on the SIRD simulations, the estimated average value of R0 in both scenarios was found to be 2.5, the one computed considering the period from the 11th of January until the 18th of January, using the official counts of the confirmed cases was found to be 4.6, while the one computed under the second scneario was found to be 3.2. Furthermore, on the estimated parameters from both scenarios, we provide tentative three-week forecasts of the evolution of the outbreak at the epicenter. Our forecasting flashes a note of caution for the presently unfolding outbreak in China. Based on the official counts for confirmed cases, the simulations suggest that the cumulative number of infected will surpass 80,000 (as a lower bound) and could reach 160,000 (with an upper bound of 330,000) by February 29. Regarding the number of deaths, simulations forecast that on the basis of the up to the 10th of February data and estimations of the actual number of infected and recovered in the population, the death toll might exceed 7,000 by February 29. However, our analysis further reveals a significant decline of the mortality rate to which various factors may have contributed, such as the severe control measures taken in Hubei, China (e.g. quarantine and hospitalization of infected individuals), but mainly it is due to the fact that the actual number of infected and recovered cases in the population is estimated to be more than twenty times higher than reported, thus resulting in a much lower mortality rate, which according to our computations is of the order of 0.15%.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

No external funding was received

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data referred to in the manuscript are available.

https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted February 25, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Data-Based Analysis, Modelling and Forecasting of the novel Coronavirus (2019-nCoV) outbreak
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Data-Based Analysis, Modelling and Forecasting of the novel Coronavirus (2019-nCoV) outbreak
Cleo Anastassopoulou, Lucia Russo, Athanasios Tsakris, Constantinos Siettos
medRxiv 2020.02.11.20022186; doi: https://doi.org/10.1101/2020.02.11.20022186
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Data-Based Analysis, Modelling and Forecasting of the novel Coronavirus (2019-nCoV) outbreak
Cleo Anastassopoulou, Lucia Russo, Athanasios Tsakris, Constantinos Siettos
medRxiv 2020.02.11.20022186; doi: https://doi.org/10.1101/2020.02.11.20022186

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (576)
  • Allergy and Immunology (867)
  • Anesthesia (306)
  • Cardiovascular Medicine (4480)
  • Dentistry and Oral Medicine (449)
  • Dermatology (385)
  • Emergency Medicine (614)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1528)
  • Epidemiology (15276)
  • Forensic Medicine (31)
  • Gastroenterology (1133)
  • Genetic and Genomic Medicine (6643)
  • Geriatric Medicine (671)
  • Health Economics (1006)
  • Health Informatics (4602)
  • Health Policy (1378)
  • Health Systems and Quality Improvement (1622)
  • Hematology (544)
  • HIV/AIDS (1275)
  • Infectious Diseases (except HIV/AIDS) (15959)
  • Intensive Care and Critical Care Medicine (1110)
  • Medical Education (626)
  • Medical Ethics (147)
  • Nephrology (674)
  • Neurology (6692)
  • Nursing (346)
  • Nutrition (1006)
  • Obstetrics and Gynecology (1152)
  • Occupational and Environmental Health (961)
  • Oncology (3369)
  • Ophthalmology (988)
  • Orthopedics (370)
  • Otolaryngology (421)
  • Pain Medicine (437)
  • Palliative Medicine (131)
  • Pathology (668)
  • Pediatrics (1703)
  • Pharmacology and Therapeutics (699)
  • Primary Care Research (717)
  • Psychiatry and Clinical Psychology (5494)
  • Public and Global Health (9284)
  • Radiology and Imaging (2223)
  • Rehabilitation Medicine and Physical Therapy (1375)
  • Respiratory Medicine (1201)
  • Rheumatology (598)
  • Sexual and Reproductive Health (720)
  • Sports Medicine (535)
  • Surgery (720)
  • Toxicology (100)
  • Transplantation (290)
  • Urology (266)